Precision Botanical CDMO & CRO

OEM Herbal Formulation Development Manufacturer & Supplier

Industrializing Natural Medicine: High-throughput screening, multi-target validation, chromatographic fingerprint standardization, and pharmaceutical-grade scale-up manufacturing for global enterprises.

Precision R&D & CDMO Portfolio

Standardized Botanical Research & Production Modules

End-to-end Contract Development and Manufacturing pipelines engineered to bridge empirical herbal knowledge with verifiable Western pharmacological criteria.

14+
Years Dedicated Botanical R&D
300+
PhDs, Analysts & Process Scientists
83+
Classic TCM Formulas Modernized
~400
Single-Herb Monograph Standards
Industrial Authority & Deep Scientific Heritage

Overcoming Phytochemical Complexity with Evidence-Based Science

Operating as Yineng Pharma (MedGence) in Changsha, China, we dismantle the historic unpredictability of botanical actives. Through high-resolution mass spectrometry, validated in vitro assays, and multi-center clinical oversight, we deliver reproducibility from crude biomass to finished therapeutic dose.

Macro Industry Solutions

Resolving the Four Bottlenecks of Global Herbal Commercialization

Global pharmaceutical corporations, dietary supplement leaders, and cosmetic giants encounter distinct systemic barriers when scaling natural botanicals. Here is how our engineering protocols solve them.

1. Batch-to-Batch Variance

Herbal compounds fluctuate dramatically across climate, soil chemistry, and harvesting windows. We enforce Geo-Authentic (Daodi) botanical sourcing, standardized harvest protocols, and multi-constituent HPLC/HPTLC fingerprint normalization to lock batch consistency within strict ±3% variance limits.

2. Poor Bioavailability

Polyphenols, triterpenoid saponins, and flavonoids frequently suffer from low water solubility and poor intestinal permeation. We engineer self-emulsifying drug delivery systems (SEDDS), phytosome nano-complexation, and micro-encapsulation to elevate therapeutic absorption up to 800%.

3. Heavy Metal & Pesticide Residue

Global regulators enforce zero-tolerance for aflatoxins, polycyclic aromatic hydrocarbons (PAHs), ethylene oxide, and organochlorine pesticides. Our supercritical CO2 and targeted macroporous resin filtration completely eliminate heavy metals and xenobiotics below USP <561> and Ph. Eur. 2.8.13 thresholds.

4. Multi-Jurisdiction Dossiers

Transitioning herbal remedies into FDA NDI, EU Novel Food, or TGA Listed Medicines demands rigorous dossier compilation. We supply validated chemistry, manufacturing, and control (CMC) dossiers, full stability study matrices, and tox reports directly ready for regulatory submissions.

Technology Roadmap 2025–2030

The Next Frontier in Botanical Active Engineering

How artificial intelligence, metabolic profiling, and green separation technologies are transforming botanical pharmaceutical development.

PHASE // 01

AI-Powered Target Screening & Network Pharmacology

Traditional screening takes years. We employ proprietary molecular docking algorithms and machine learning-driven network pharmacology to simulate interactions between complex multi-component plant extracts and biological receptor pathways, cutting exploratory timelines by 65%.

In Silico Binding Affinity Matrix
PHASE // 02

Continuous Countercurrent & Supercritical Fluid Extraction

Replacing antiquated thermal reflux with closed-loop subcritical liquid extraction and supercritical CO2 recovery. This avoids thermal degradation of heat-sensitive sesquiterpenes, preserves native stereochemistry, and eliminates organic solvent residues completely.

Zero-Residue Bioactive Concentrates
PHASE // 03

Process Analytical Technology (PAT) & Real-Time Monitoring

Integrating online near-infrared (NIR) sensors and automated high-pressure chromatography within our industrial scale-up extraction loops, ensuring continuous validation of target active concentrations during live production runs.

Real-Time In-Line Content Telemetry
PHASE // 04

Enzyme-Assisted Biotransformation & Bio-Catalysis

Utilizing immobilized biocatalysts and microbial glycosidases to selectively cleave glycosidic bonds, converting rare saponins and bound flavonoids (e.g., Ginsenoside Rg3, Rh2) into highly bioactive free aglycones with dramatic increases in cellular uptake.

Rare Aglycone Yield Amplification
PHASE // 05

Metabolic Engineering & Synthetic Biology Integration

Addressing endangered or trace botanical components via yeast-based heterologous expression platforms, allowing multi-metric batch scaling without depleting wild biological resources or violating biodiversity protection treaties.

Sustainable Botanical Bio-Identicals
PHASE // 06

Full Clinical Translation & Phase I–IV Multi-Center Trials

Guiding natural leads through formal human GCP clinical trials. In collaboration with provincial university hospitals, we design double-blind, randomized, placebo-controlled protocols targeting metabolics, cognitive health, oncology adjuvant care, and respiratory inflammation.

FDA/NMPA-Compliant Clinical Datasets
Smart Manufacturing & Infrastructure

China Factory 4.0: Structural Advantages in Botanical Supply Chains

Combining direct geographical proximity to the world’s largest botanical raw-material reserves with cutting-edge automated industrial facilities.

Upstream Daodi Cultivation Control

Our raw herb supply originates from certified GAP (Good Agricultural Practices) partner cultivation bases across Hunan, Guizhou, Yunnan, and Sichuan. Full geochemical tracking ensures optimal mineral profiles, verified botanical taxonomy, and protection against chemical adulteration at the root level.

Fully Automated SCADA & MES Architecture

Our extraction towers and distillation columns run on closed-circuit Siemens SCADA systems. Over 2,400 data sensors record temperature, pressure, flow rate, and solvent recovery efficiency in real time, preventing thermal degradation and assuring total electronic batch record (EBR) integrity.

Unmatched Unit Economics & Scalability

Industrial scale-up delivers an exceptional cost advantage without sacrificing compliance. Our collaborative facilities handle over 10,000 metric tons of dried biomass annually, providing global clients with predictable volume pricing, hedge protection against inflationary spikes, and immediate capacity reservation.

Global Regulatory Assurance

Meeting the Stringent Requirements of Tier-1 Global Procurement

Designed for multinational QA/QC auditors, regulatory compliance teams, and strategic sourcing directors requiring comprehensive risk mitigation.

United States FDA cGMP (21 CFR Part 111 / 210 / 211)

Complete facility alignment with US cGMP guidelines. Full traceability from seed stock to finished blend, validated cleaning protocols to prevent cross-contamination, Master Manufacturing Records (MMR), and automated electronic signature record controls.

European Union & Pharmacopoeia (Ph. Eur.) Standards

Full conformance with European Medicines Agency (EMA) botanical monographs. Guaranteed absence of ethylene oxide treatment, full testing for PAHs (Benzo[a]pyrene < 10 ppb), pyrrolizidine alkaloids, and total micro-organism counts strictly complying with Ph. Eur. Chapter 5.1.8.

Australasia & Southeast Asia (TGA & HALAL/KOSHER)

Experienced in preparation of dossiers for Australia Therapeutic Goods Administration (TGA) listed medicines, GMP mutual recognition frameworks, and globally accepted certifications including ISO 22000, HACCP, Halal, Kosher, and Organic (NOP/EU).

Peer-Reviewed Credibility & Strategic Alliances

Endorsed by Premier Pharmaceutical Groups & University Hospitals

Our translational research engine drives hospital-grade preparations and blockbuster pharmaceutical innovations across Greater China and global export channels.

Beijing Tongrentang Group Beijing Tongrentang
CR Sanjiu Pharmaceutical CR Sanjiu Medical
Sunflower Pharmaceutical Sunflower Pharma
Livzon Pharmaceutical Group Livzon Pharma
Dihon Pharmaceutical Dihon Pharma
Golden Throat Holdings Golden Throat
Yangtzi River Pharmaceutical Group Yangtzi River Pharma
Humanwell Healthcare Humanwell Healthcare
Shuguang Hospital Affiliated to Shanghai University of TCM Shuguang Hospital
Hunan Province Directly Affiliated TCM Hospital Hunan Affiliated TCM
First Hospital of Hunan University of Chinese Medicine 1st Affiliated HN TCM
Second Xiangya Hospital of Central South University 2nd Xiangya Hospital
Technical & Strategic Procurement FAQ

Addressing Technical Audits, IP Security & Scale-Up Mechanics

Direct, transparent answers compiled from our senior regulatory scientists and technical engineering leads.

How do you guarantee proprietary IP protection during OEM formulation development?

We implement strict corporate confidentiality protocols under bilateral NDA agreements. All custom synthesis parameters, raw-material ratios, and extraction kinetics are isolated on segregated, air-gapped internal servers with encrypted access rights. Your formula remains 100% your exclusive intellectual property; we never cross-deploy client formulas across commercial projects.

What analytical methodologies are used to validate chemical fingerprints?

We deploy high-performance thin-layer chromatography (HPTLC) for qualitative visual identification against botanical reference standards, coupled with HPLC-DAD, LC-MS/MS, and GC-MS for quantitative assaying of marker compounds. We also establish chromatographic fingerprint similarity scores (typically >0.95 against target standard profiles) to confirm total botanical authenticity.

Can you transition clinical-stage research formulas directly into industrial CDMO volume?

Yes. That is the foundational benefit of our integrated CRO + CDMO model. Rather than contracting research to an academic lab that lacks scale comprehension, our pilot plants operate with identical hydro-mechanical principles as our full-scale 10,000-ton industrial production partners. Process parameters transfer seamlessly with zero loss of yield or unexpected crystallization.

What safety toxicity data packages do you supply for regulatory submissions?

We provide full GLP-compliant preclinical toxicology packages including acute oral toxicity (LD50), Ames bacterial reverse mutation tests, in vitro mammalian chromosomal aberration assays, in vivo micronucleus testing, and 28-day or 90-day repeat-dose chronic toxicity profiling, fully satisfying US FDA NDI and EFSA safety dossiers.

Which finished dosage delivery formats can your CDMO lines produce?

We supply bulk active pharmaceutical ingredients (powders, concentrated extracts, micro-emulsions, volatile oils) as well as finished, packaged oral forms: hard-shell vegetarian/gelatin capsules, softgels, bi-layer tablets, water-dispersible effervescent granules, functional oral liquids, and liposomal sachets with full secondary blister and carton packaging.

How do you manage cross-season active ingredient variance in multi-herb formulations?

Our database contains chemical profiles across 14+ years of seasonal harvests throughout China's micro-climates. We anticipate regional yield drops by maintaining strategic reserve inventories of standardized extracts, allowing precise mathematical batch-blending to hit exact target concentration markers regardless of current season agricultural variations.

Direct Commercial Engagement

Select an R&D or Manufacturing Program for Immediate Scope

Initiate your feasibility assessment with our scientific directors. Guaranteed response within 24 working hours.

Accelerate Your Botanical Pipeline with Validated Science

Whether you require targeted active ingredient isolation, classic TCM formula modernization, full preclinical toxicological dossiers, or high-volume cGMP contract manufacturing, our scientists are prepared to review your technical brief.